© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing β2-adrenergic receptors in the heart
Baker Medical Research Institute and the Alfred Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia
* Corresponding author. Tel.: +61-39-522-4333; fax: +61-39-521-1362 xiaojun.du{at}baker.edu.au
Objective: To explore long-term cardiac phenotype in transgenic (TG) mice with 300-fold overexpression of β2-adrenergic receptors (AR). Methods: Echocardiography was performed serially on a cohort of wild-type and TG mice (n = 26 each) between 4 and 15 months of age. Survival was monitored and autopsy and histological examinations were performed. Results: Heart rate was higher in TG than in wild-type mice throughout the study period. The left ventricular dimensions and fractional shortening were similar between TG and wild-type groups during 4–6 months. Starting at 9 months, however, TG mice showed progressive reduction in fractional shortening and systolic wall thickening, and increase in left ventricular dimensions and left ventricular mass, indicating onset of heart failure, left ventricular hypertrophy and remodeling. Abnormal waveforms in the electrocardigram and episodes of ventricular ectopic beats were also observed in TG mice. Death of TG mice started at 8.5 months, and the cumulative mortality was 81% by 15 months (P<0.0001 vs. 4% in wild-type mice). The majority of deaths were due to severe heart failure, indicated by cardiac dilatation, lung congestion, pleural effusion and atrial thrombus. Left ventricular sections showed widespread interstitial fibrosis, loss of myocytes and myocyte hypertrophy in TG mice. Conclusions: A high level of β2AR overexpression results in cardiomyopathy and heart failure. The onset was slower and the expression levels of receptors required are much higher than previously described for the β1AR overexpression.
KEYWORDS Cardiomyopathy; Heart failure; Autonomic nervous system; Receptors; Ultrasound
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Pretorius, X.-J. Du, E. A. Woodcock, H. Kiriazis, R. C.Y. Lin, S. Marasco, R. L. Medcalf, Z. Ming, G. A. Head, J. W. Tan, et al. Reduced Phosphoinositide 3-Kinase (p110{alpha}) Activation Increases the Susceptibility to Atrial Fibrillation Am. J. Pathol., September 1, 2009; 175(3): 998 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Hinton Jr., C. M. Alfieri, S. A. Witt, B. J. Glascock, P. R. Khoury, D. W. Benson, and K. E. Yutzey Mouse heart valve structure and function: echocardiographic and morphometric analyses from the fetus through the aged adult Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2480 - H2488. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishizawa, Y.-T. Shen, F. Rossi, C. Hong, J. Robbins, Y. Ishikawa, J. Sadoshima, D. E. Vatner, and S. F. Vatner Altered autonomic control in conscious transgenic rabbits with overexpressed cardiac Gs{alpha} Am J Physiol Heart Circ Physiol, February 1, 2007; 292(2): H971 - H975. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Peart and G. J. Gross Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1746 - H1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Billman, M. Kukielka, R. Kelley, M. Moustafa-Bayoumi, and R. A. Altschuld Endurance exercise training attenuates cardiac beta2-adrenoceptor responsiveness and prevents ventricular fibrillation in animals susceptible to sudden death Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2590 - H2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kiriazis, X.-J. Du, X. Feng, E. Hotchkin, T. Marshall, S. Finch, X.-M. Gao, G. Lambert, J. K. Choate, and D. M. Kaye Preserved left ventricular structure and function in mice with cardiac sympathetic hyperinnervation Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1359 - H1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshizawa, G. E. Kissling, J. A. Johnson, N. P. Clayton, N. D. Flagler, and A. Nyska Chemical-Induced Atrial Thrombosis in NTP Rodent Studies Toxicol Pathol, August 1, 2005; 33(5): 517 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Burniston, L.-B. Tan, and D. F. Goldspink {beta}2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle J Appl Physiol, April 1, 2005; 98(4): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Ashley, J. Powers, M. Chen, R. Kundu, T. Finsterbach, A. Caffarelli, A. Deng, J. Eichhorn, R. Mahajan, R. Agrawal, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo Cardiovasc Res, January 1, 2005; 65(1): 73 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Barki-Harrington, C. Perrino, and H. A Rockman Network integration of the adrenergic system in cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 391 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du Gender modulates cardiac phenotype development in genetically modified mice Cardiovasc Res, August 15, 2004; 63(3): 510 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Gao, A. Agrotis, D. J. Autelitano, E. Percy, E. A. Woodcock, G. L. Jennings, A. M. Dart, and X.-J. Du Sex Hormones and Cardiomyopathic Phenotype Induced by Cardiac {beta}2-Adrenergic Receptor Overexpression Endocrinology, September 1, 2003; 144(9): 4097 - 4105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pareja, O. Sanchez, J. Lorita, M. Soley, and I. Ramirez Activated epidermal growth factor receptor (ErbB1) protects the heart against stress-induced injury in mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R455 - R462. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du, T. J. Cole, N. Tenis, X.-M. Gao, F. Kontgen, B. E. Kemp, and J. Heierhorst Impaired Cardiac Contractility Response to Hemodynamic Stress in S100A1-Deficient Mice Mol. Cell. Biol., April 15, 2002; 22(8): 2821 - 2829. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du Sympathoadrenergic mechanisms in functional regulation and development of cardiac hypertrophy and failure: findings from genetically engineered mice Cardiovasc Res, June 1, 2001; 50(3): 443 - 453. [Full Text] [PDF] |
||||







